ABSTRACT
INTRODUCTION
A suture is a strand of material used to approximate tissue or ligate blood vessels.
Ligatures, often synonymous with sutures, are the same strands of material used to tie ends of structures to stop leakage, for example a blood vessels [1] . Sutures are generally categorized by a combination of their absorption, their fibre construct, or their origin as shown in Table 1 . With ever-changing technology and a better understanding of cellular science, it is inevitable that suture technology will be enhanced to provide better quality and outcomes. Strength, different degrees of absorption, sterility, and high knot security, lack of allergic reaction together with ease of handling are among the important properties of an ideal suture material [1] [2] [3] .
This article will give an in depth focus on the current trends in modifying suture materials to make them biologically active, and highlight novel studies that explore new possibilities.
Categorization Types
Based 
BIOACTIVE SUTURES APPLICATION
Several applications of suture modifications have been reported. In the following section, a review of the different trials is discussed.
Summary of reported trials is found in Table 2 .
BIOACTIVE SUTURES IN DRUG DELIVERY
Commonly used biomaterials in sutures are recognised as foreign materials within the body, and often trigger a host of immune response. These processes can increase the chances of a surgical site infection (SSI) [4] .
Additionally, the suture itself can be a vessel for bacterial colonisation that can result in an SSI [5] .
The use of bioactive sutures coated with antimicrobial drugs and anaesthetics have been shown to be effective in reducing inflammation and bacterial infection in the wound site [6, 7] .
The first commercially available antimicrobial suture was a polyglactin suture loaded with triclosan (Vicryl Plus®) in 2002 [8] . The initial method of drug delivery was to coat the suture with a second biodegradable layer but there was limited control over the rate of drug release, which is a critical factor for optimised wound healing [9] . 
BIOACTIVE SUTURE IN GROWTH FACTOR DELIVERY
Different bio-active molecules including peptides and hormones influence cell division, growth, differentiation and protein synthesis.
Growth factors were being used to aid healing in tissues with variable level of success [19] . In-vivo assessments using rat's colonic anastomosis repair showed that a significant difference in the adhesion index with VicrylADSCs sutures compared to cell free sutures [40] . In another report, the authors investigated these sutures with icodextrix 4% intraperitoneal injection to decrease adhesion formation in syngeneic BDIX rats and showed increased anastomosis resistance with a similar adhesion index to conventional sutures [41] .
Vicryl-ADSCs sutures were also investigated in modulating the inflammatory response in rat's tracheal resection repair [42] . Gelatin suture coating with intended application in Achilles tendon healing using rhPDGF-BB
Biologically active molecule incorporation
Vicryl-Mersilk®/silver-doped bioglass coating. (Blaker et al., 2004) Intended in the delivery of silver ion for antibacterial properties. Intended in the delivery of active molecule to promote angiogenesis.
Polybutester monofilament sutures / fibrinogen / Doxycycline coating. Intended for tenocytes delivery. Table 2 . Summarised literature implicating the use of different biologically active suture materials.
3.
CONCLUSION.
As summarised in this article, the scope of 
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